COLISTIMETAT DE SODIU ACCORD 1000000UI powder for injection / infusion solution medication leaflet

J01XB01 colistimethate sodium • Antiinfectives for systemic use | Other antibacterials | Polymyxins

Colistimethate sodium is an antibiotic used to treat severe infections caused by gram-negative bacteria, particularly in cases of resistance to other antibiotics. It is effective against bacteria such as Pseudomonas aeruginosa and Acinetobacter baumannii.

The medication is administered intravenously or via inhalation, depending on the location of the infection and the patient's condition. It is important to use it as prescribed by your doctor to prevent the development of bacterial resistance.

Side effects may include renal toxicity, neurotoxicity (dizziness, muscle weakness), or allergic reactions. In rare cases, severe complications may occur, requiring immediate medical intervention.

Patients should inform their doctor about any other medications being used or pre-existing conditions, such as renal insufficiency, to ensure the safe use of colistimethate sodium.

General data about COLISTIMETAT DE SODIU ACCORD 1000000UI

Substance: colistimethate sodium

Date of last drug list: 01-12-2024

Commercial code: W70698002

Concentration: 1000000UI

Pharmaceutical form: powder for injection / infusion solution

Quantity: 10

Product type: generic

Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).

Marketing authorisation

Manufacturer: ACCORD HEALTHCARE POLSKA SP. Z. O.O. - POLONIA

Holder: ACCORD HEALTHCARE POLSKA SP. Z.O.O. - POLONIA

Number: 15667/2024/02

Shelf life: 2 years-after packing for marketing;after reconstitution-it is used immediately

Pharmaceutical forms available for colistimethate sodium

Concentrations available for colistimethate sodium

1000000UI, 1662500UI